The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(4-((4-amino-3-(2-aminobenzo[d]oxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)piperidine-1-carbonyl)-N-hydroxythiophene-2-carboxamide ID: ALA4879288
PubChem CID: 164627138
Max Phase: Preclinical
Molecular Formula: C24H23N9O4S
Molecular Weight: 533.57
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc2cc(-c3nn(CC4CCN(C(=O)c5ccc(C(=O)NO)s5)CC4)c4ncnc(N)c34)ccc2o1
Standard InChI: InChI=1S/C24H23N9O4S/c25-20-18-19(13-1-2-15-14(9-13)29-24(26)37-15)30-33(21(18)28-11-27-20)10-12-5-7-32(8-6-12)23(35)17-4-3-16(38-17)22(34)31-36/h1-4,9,11-12,36H,5-8,10H2,(H2,26,29)(H,31,34)(H2,25,27,28)
Standard InChI Key: XKQWUBPQPZBRPQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
32.4303 -29.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4292 -30.6759 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1372 -31.0848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1355 -29.4475 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8441 -29.8527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8489 -30.6713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6289 -30.9198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1063 -30.2547 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.6212 -29.5953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1383 -31.9020 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.8691 -28.8166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6674 -28.6420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8846 -31.6909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3396 -32.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5961 -33.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6819 -31.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9413 -32.6269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4000 -33.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8174 -33.9465 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.6167 -33.7673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6932 -32.9518 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.2301 -34.3073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.2114 -29.2485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0066 -29.0766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2587 -28.2989 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7091 -27.6928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9075 -27.8644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0577 -28.1273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6057 -28.7335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.3086 -27.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0804 -27.0941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0787 -26.2769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3009 -26.0259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8221 -26.6881 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
38.0467 -25.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5922 -24.6408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.3380 -23.8642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.2470 -25.0811 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
3 10 1 0
9 11 1 0
11 12 1 0
13 14 2 0
14 15 1 0
15 18 2 0
17 16 2 0
16 13 1 0
7 13 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 17 1 0
20 22 1 0
12 23 1 0
12 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
28 29 2 0
28 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 30 1 0
33 35 1 0
35 36 1 0
36 37 1 0
35 38 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 533.57Molecular Weight (Monoisotopic): 533.1594AlogP: 2.53#Rotatable Bonds: 5Polar Surface Area: 191.31Molecular Species: NEUTRALHBA: 12HBD: 4#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 3CX Acidic pKa: 8.38CX Basic pKa: 3.76CX LogP: 1.33CX LogD: 1.28Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.19Np Likeness Score: -1.28
References 1. Zhang M, Wei W, Peng C, Ma X, He X, Zhang H, Zhou M.. (2021) Discovery of novel pyrazolopyrimidine derivatives as potent mTOR/HDAC bi-functional inhibitors via pharmacophore-merging strategy., 49 [PMID:34314844 ] [10.1016/j.bmcl.2021.128286 ]